Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Rabheh Abdul Aziz, MD, MS

  • Lyme Arthritis on the Uptick in Western New York Area. Rabheh Abdul Aziz (Principal Investigator). Rheumatology Research Foundation. $1,000. 6/1/2018-8/1/2018.
  • Infection at Time of Presentation and During the Course of Juvenile Dermatomyositis. Rabheh Abdul Aziz (Principal Investigator). Rheumatology Research Foundation. $500. 6/1/2018-8/1/2018.

Stephanie Anzman-Frasca, PhD

  • Preventing Obesity Through Interventions During Infancy. Stephanie Anzman-Frasca (Principal Investigator). Pennsylvania State University. $59,798. 6/1/2018-3/1/2019.

Susan Baker, MD, PhD

  • Predicting Response to Standardized Pediatric Colitis Therapy: The PROTECT Study. Susan Baker (Principal Investigator). Connecticut Children‘s Medical Center. $26,605. 8/1/2012-4/1/2017.

Matthew Barth, MD

  • Targeting Oncogenic MicroRNAs in MYC Associated Aggressive B Cell Non-Hodgkin Lymphoma. Matthew Barth (Principal Investigator). Roswell Park Alliance Foundation. $70,000. 5/1/2019-4/1/2020.

Sara Berkelhamer, MD

  • Intraosseous Epinephrine: An Alternate Route of Drug Administration in Neonatal Resuscitation. Sara Berkelhamer (Principal Investigator). American Academy of Pediatrics: Neonatal Resuscitation Program. $50,000. 1/1/2019-12/1/2019.
  • Saving Lives at Birth. Sara Berkelhamer (Co-Investigator). USAID/Gates Foundation. $250,000. 7/1/2018-1/1/2020.
  • Targeted Antioxidant Therapy for the Treatment of BPD. Sara Berkelhamer (Principal Investigator). Wildermuth Research Foundation. $10,000. 5/1/2018-4/1/2019.

Kathleen Bethin, MD, PhD

  • T1D Exchange Clinic Registry Celiac Disease Additional Data Collection. Kathleen Bethin (Principal Investigator). Jaeb Center for Health Research. $9,091. 7/1/2014-10/1/2016.
  • Residual C-Peptide in Patients with Type 1 Diabetes. Kathleen Bethin (Principal Investigator). T1D Exchange. $9,545. 1/1/2012-1/1/2018.
  • Type 1 Diabetes TrialNet. Kathleen Bethin (Co-Investigator), Indrajit Majumdar (Co-Investigator), Teresa Quattrin (Principal Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Gale Burstein, MD, MPH

  • NYSDOH Evaluation of Methods for Improving Screening for Chlamydia among Young Women Seen in Primary Care Settings. Gale Burstein (Co-Investigator). Centers for Disease Control and Prevention. $107,000. 1/1/2015-1/1/2017.

Melinda Cameron, MD

  • New York State Children‘s Environmental Health Center of Excellence. Melinda Cameron (Principal Investigator). Icahn School of Medicine at Mount Sinai. $125,000. 11/1/2017-10/1/2018.
  • Western New York Prevention Resource Center. Melinda Cameron (Principal Investigator). New York State Department of Health. $229,110. 1/1/1994-1/1/2021.

Praveen Chandrasekharan, MD

  • Optimizing Transition with Delayed Umbilical Cord Clamping and Supplemental Oxygen during Preterm Resuscitation with Perinatal Asphyxia. Praveen Chandrasekharan (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $79,750. 7/1/2019-6/1/2021.
  • Rochester-Buffalo Neonatal Research Group. Praveen Chandrasekharan (Co-Investigator), Anne Marie Reynolds (Principal Investigator). University of Rochester. $300,025. 4/1/2016-3/1/2021.

Leonard Epstein, PhD

  • Enhancing Alternatives to Eating in Infants. Leonard Epstein (Co-Investigator), Kai Ling Kong (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,683,730. 8/1/2016-7/1/2021.
  • Can Reinforcing Alternatives to Food Prevent Weight Gain in Children?. Leonard Epstein (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $1,723,154. 8/1/2016-7/1/2021.
  • The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application. Leonard Epstein (Principal Investigator), Teresa Quattrin (Co-Investigator). National Institutes of Health. $5,615,697. 6/1/2016-5/1/2021.
  • Evaluating the Impact of Tobacco Control Policies in a Rapidly Changing Nicotine Delivery Market. Leonard Epstein (Principal Investigator). Virginia Polytechnic Institute and State University. $35,041. 4/1/2016-3/1/2021.
  • Clinical Translational Science Award (CTSA). Leonard Epstein (Co-Investigator), John Canty, Jr. (Co-Principal Investigator), Margarita Dubocovich (Principal Investigator), Peter Elkin (Co-Investigator), Steven Fliesler (Co-Investigator), Alan Hutson (Co-Investigator), Gene Morse (Co-Investigator), Sanjay Sethi (Co-Investigator), Laurene Tumiel Berhalter (Co-Investigator). National Institutes of Health. $16,000,000. 1/1/2016-1/1/2019.
  • Sensitization of the Reinforcing Value of Food as a Predictor of Weight Change in Adolescents. Leonard Epstein (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $1,993,750. 1/1/2016-1/1/2021.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Leonard Epstein (Co-Principal Investigator), Lucy Mastrandrea (Co-Investigator), Teresa Quattrin (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 9/1/2015-8/1/2020.
  • Using Prospection to Improve Obesity Treatment. Leonard Epstein (Principal Investigator), Teresa Quattrin (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,191,299. 1/1/2015-12/1/2019.
  • Food Marketing Vulnerability and Increased Risk for Weight Gain in Adolescents. Leonard Epstein (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $58,812. 1/1/2015-1/1/2018.

Howard Faden, MD

  • Research on C. difficile. Howard Faden (Principal Investigator). Wildermuth Foundation. $20,000. 1/1/2016-12/1/2016.

Danielle Goetz, MD

  • A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System. Danielle Goetz (Principal Investigator). Cincinnati Children's Hospital Medical Center. $76,950. 6/1/2017-12/1/2018.
  • Implementation of the Depression and Anxiety Guidelines: Award for a Mental Health Coordinator. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $121,384. 1/1/2016-12/1/2018.
  • TherapeuticS Development Center (TDC). Danielle Goetz (Co-Investigator), Carla Frederick (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $443,986. 1/1/2015-12/1/2018.
  • Additional Research Coordinator (ARC) Award. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $243,760. 1/1/2015-12/1/2018.
  • Success with Therapies Research Consortium. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation. $111,240. 8/1/2014-7/1/2018.
  • The EPIC Observational Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas aeruginosa Acquisition and Early Anti-Pseudomonal Therapy in Children with Cystic Fibrosis. Danielle Goetz (Principal Investigator). Cystic Fibrosis Foundation Therapeutics, Inc. $29,045. 3/1/2014-3/1/2019.

Oscar Gómez, MD, PhD

  • Studies on Emergent Diarrheagenic E. coli Pathogens. Oscar Gómez (Principal Investigator). National Institute of Allergy and Infectious Diseases. $675,282. 7/1/2016-11/1/2018.

Michelle Hartley-McAndrew, MD

Mark Hicar, MD, PhD

  • Defining the Epitopes of Anti-Kawasaki Disease Antibodies Identified from Circulating Plasmablasts During Kawasaki Disease. Mark Hicar (Principal Investigator). Wildermuth Foundation. $25,000. 5/1/2019-4/1/2020.
  • The Role of Non-Broadly Neutralizing Antibodies Targeting gp41 Structural Epitopes in Long-Term Nonprogression of HIV Infection. Mark Hicar (Principal Investigator). National Institute of Allergy and Infectious Diseases. $1,174,997. 2/1/2016-1/1/2021.

Lucy Holmes, MD, MPH

  • Project ASTHMA - Aligning with Schools To Help Manage Asthma. Lucy Holmes (Principal Investigator), Heather Lehman (Co-Investigator). University at Buffalo Clinical and Translational Science Institute. $49,650. 7/1/2018-6/1/2019.
  • Individual Development Awards Program. Lucy Holmes (Principal Investigator). United University Professions. $1,000. 1/1/2017-12/1/2017.

Shilpa Jain, MD, MPH

  • Genotype and Phenotype Analysis of Adolescents with Heavy Menstrual Bleeding and Low von Willebrand Activity. Shilpa Jain (Principal Investigator). Baylor College of Medicine. $300. 5/1/2017-5/1/2019.

James Jarvis, MD

  • Identifying Causal Variants in Juvenile Arthritis Using a Massively Parallel Reporter Assay. James Jarvis (Principal Investigator). National Institute of Arthritis and Musculoskeletal and Skin Diseases. $385,990. 9/1/2018-8/1/2020.
  • Genetics and Epigenetics in JIA CD4+ T Cells. James Jarvis (Principal Investigator). Rheumatology Research Foundation. $400,000. 7/1/2017-6/1/2019.
  • Developing Biomarkers for Juvenile Arthritis from Plasma Exosomes. James Jarvis (Principal Investigator). Wildermuth Foundation. $25,000. 6/1/2017-5/1/2018.
  • Interplay Between Genetics and Epigenetics in Polyarticular JIA. James Jarvis (Principal Investigator). Arthritis Foundation. $730,998. 12/1/2016-11/1/2018.
  • Plasma Exosomes in Juvenile Dermatomyositis. James Jarvis (Principal Investigator). Cure JM Foundation. $25,000. 7/1/2016-5/1/2018.
  • Arthritis Small Grant - Equipment. James Jarvis (Principal Investigator). Fraternal Order of Eagles. $3,344. 6/1/2015-5/1/2019.
  • Arthritis Small Grant - Gift Cards. James Jarvis (Principal Investigator). Fraternal Order of Eagles. $1,000. 6/1/2015-5/1/2019.

Kara Kelly, MD

  • Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia. Kara Kelly (Co-Principal Investigator). National Cancer Institute. $200,000. 12/1/2017-11/1/2019.
  • The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships Across Time and Around Periods of Distress. Kara Kelly (Co-Investigator). National Cancer Institute. $722,488. 6/1/2017-6/1/2022.
  • A Comprehensive Assessment of Oral Chemotherapy Adherence in Pediatric ALL. Kara Kelly (Co-Principal Investigator). Roswell Park Alliance Foundation. $50,000. 6/1/2017-6/1/2018.

Kai Ling Kong, PhD

  • Enhancing Alternatives to Eating in Infants. Kai Ling Kong (Co-Investigator), Leonard Epstein (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,683,730. 8/1/2016-7/1/2021.
  • Developing the Methodology to Measure Food Reward in Young Infants (3-6 months old). Kai Ling Kong (Principal Investigator). University at Buffalo IMPACT. $21,000. 2/1/2016-2/1/2017.
  • Methodology to Measure Infant Food Reinforcement. Kai Ling Kong (Principal Investigator). Research Institute on Addictions. $24,491. 11/1/2015-10/1/2016.
  • CTSA Pilot: Pilot Study on Pediatric Obesity Prevention by Maternal Smoking Cessation in Pregnancy and Lactation. Kai Ling Kong (Co-Investigator), Xiaozhong Wen (Principal Investigator). National Institutes of Health. $75,000. 11/1/2015-3/1/2017.

Bree Kramer, DO

  • The Use of Near-infrared Spectroscopy in Children with Traumatic Brain Injury to Predict Adverse Events. Bree Kramer (Principal Investigator). Wildermuth Foundation. $9,600. 1/1/2018-1/1/2019.
  • Transmitted Lung Pressure Values with Biphasic Chest Cuirass. Bree Kramer (Principal Investigator). Kaleida Health Foundation. $4,000. 1/1/2018-1/1/2019.

Vasanth Kumar, MD

  • Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension. Vasanth Kumar (Principal Investigator). National Heart, Lung, and Blood Institute. $234,132. 9/1/2017-8/1/2022.

Dennis Kuo, MD, MHS

  • Medical Director, American Academy of Pediatrics Chapter Quality Network. Dennis Kuo (Principal Investigator). American Academy of Pediatrics. $50,000. 3/1/2018-2/1/2020.
  • DANY Ambulatory Care Training Enhancement Program Award. Dennis Kuo (Co-Investigator). New York State. $595,743. 1/1/2018-6/1/2021.
  • DANY Ambulatory Care Training Enhancement Program Award Grant. Dennis Kuo (Co-Investigator), Michael Aronica (Co-Investigator), Roberto Diaz Del Carpio (Co-Investigator), Ranjit Singh (Co-Investigator), Andrew Symons (Principal Investigator), Laurene Tumiel Berhalter (Co-Investigator), Diana Wilkins (Co-Investigator). Department of Health. 1/1/2018-6/1/2021.
  • Community-Based Integrated Service Systems. Dennis Kuo (Principal Investigator). New York State Office of Children and Family Services. $97,933. 8/1/2017-7/1/2021.
  • Building Health Through Care Coordination for Children with Medical Complexity. Dennis Kuo (Principal Investigator). Lucille Packard Foundation for Children‘s Health. $68,903. 5/1/2017-8/1/2018.

Heather Lehman, MD, FAAAAI

  • Project ASTHMA - Aligning with Schools To Help Manage Asthma. Heather Lehman (Co-Investigator), Lucy Holmes (Principal Investigator). University at Buffalo Clinical and Translational Science Institute. $49,650. 7/1/2018-6/1/2019.
  • Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators. Heather Lehman (Co-Investigator), Bruce Miller (Principal Investigator), Beatrice Wood (Principal Investigator). NIH/NHLBI. $3,987,363. 8/1/2015-7/1/2020.

Indrajit Majumdar, MBBS

  • A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes and Clinical Study. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Principal Investigator). AstraZeneca. 1/1/2017-1/1/2020.
  • Targeting Polyamines Using DFMO in Persons with T1D. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Co-Principal Investigator). Indiana University Board of Trustees. $48,953. 12/1/2016-5/1/2019.
  • A 6-Month, Multi-Center, Randomized, Open-Label, 2-Arm, Parallel Group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus Injected Once Daily in Children and Adolescents with Type 1 Diabetes. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Principal Investigator). Sanofi. 12/1/2016-12/1/2018.
  • Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects with Obesity. A 56-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Multi-National Trial. Indrajit Majumdar (Co-Investigator), Lucy Mastrandrea (Principal Investigator). NovoNordisk. 11/1/2016-11/1/2018.
  • Type 1 Diabetes TrialNet. Indrajit Majumdar (Co-Investigator), Kathleen Bethin (Co-Investigator), Teresa Quattrin (Principal Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Lucy Mastrandrea, MD, PhD

  • Assessment of Adrenal Function After ACTH Treatment in Children with Infantile Spasms. Lucy Mastrandrea (Co-Principal Investigator), Osman Farooq (Co-Principal Investigator). Wildermuth Foundation. $25,000. 5/1/2019-4/1/2020.
  • A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes and Clinical Study. Lucy Mastrandrea (Principal Investigator), Indrajit Majumdar (Co-Investigator). AstraZeneca. 1/1/2017-1/1/2020.
  • Targeting Polyamines Using DFMO in Persons with T1D. Lucy Mastrandrea (Co-Principal Investigator), Indrajit Majumdar (Co-Investigator). Indiana University Board of Trustees. $48,953. 12/1/2016-5/1/2019.
  • A 6-Month, Multi-Center, Randomized, Open-Label, 2-Arm, Parallel Group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus Injected Once Daily in Children and Adolescents with Type 1 Diabetes. Lucy Mastrandrea (Principal Investigator), Indrajit Majumdar (Co-Investigator). Sanofi. 12/1/2016-12/1/2018.
  • Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects with Obesity. A 56-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Multi-National Trial. Lucy Mastrandrea (Principal Investigator), Indrajit Majumdar (Co-Investigator). NovoNordisk. 11/1/2016-11/1/2018.
  • A 24-Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28-Week Long-Term Safety Extension Phase Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Subjects Age 10-24 Years. Lucy Mastrandrea (Principal Investigator). AstraZeneca. 9/1/2016-9/1/2018.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Lucy Mastrandrea (Co-Investigator), Leonard Epstein (Co-Principal Investigator), Teresa Quattrin (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 9/1/2015-8/1/2020.

Teresa Quattrin, MD

  • Phase 2 SIMPONI to Arrest B-cell Loss in Type 1 Diabetes. Teresa Quattrin (Principal Investigator). Janssen Research and Development, LLC. $66,371. 1/1/2017-1/1/2019.
  • The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care – CCC – Lead Application. Teresa Quattrin (Co-Investigator), Leonard Epstein (Principal Investigator). National Institutes of Health. $5,615,697. 6/1/2016-5/1/2021.
  • Delay Discounting as a Target for Self-Regulation in Prediabetes. Teresa Quattrin (Co-Investigator), Leonard Epstein (Co-Principal Investigator), Lucy Mastrandrea (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $2,417,153. 9/1/2015-8/1/2020.
  • Using Prospection to Improve Obesity Treatment. Teresa Quattrin (Co-Investigator), Leonard Epstein (Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. $2,191,299. 1/1/2015-12/1/2019.
  • Type 1 Diabetes TrialNet. Teresa Quattrin (Principal Investigator), Kathleen Bethin (Co-Investigator), Indrajit Majumdar (Co-Investigator). National Institutes of Health. $421,720. 9/1/2008-6/1/2018.

Munmun Rawat, MD

  • Femoral Occlusion During Neonatal Cardiopulmonary Resuscitation. Munmun Rawat (Principal Investigator). American Academy of Pediatrics: Neonatal Resuscitation Program. $47,000. 1/1/2019-12/1/2019.
  • Vasopressin and Epinephrine in Neonatal Resuscitation. Munmun Rawat (Principal Investigator). University at Buffalo: Dr. Henry C. and Bertha H. Buswell Fellowship. 3/1/2017-3/1/2020.
  • Use of Vasopressin in Neonatal Resuscitation. Munmun Rawat (Principal Investigator). Canadian Paediatric Society. $12,500. 1/1/2017-1/1/2018.

Anne Marie Reynolds, MD, MPH

  • Developmental Impact of NICU Exposures (DINE). Anne Marie Reynolds (Principal Investigator). National Institutes of Health. $5,300,000. 9/1/2016-8/1/2023.
  • Rochester-Buffalo Neonatal Research Group. Anne Marie Reynolds (Principal Investigator), Praveen Chandrasekharan (Co-Investigator). University of Rochester. $300,025. 4/1/2016-3/1/2021.
  • Neonatal Research Network. Anne Marie Reynolds (Co-Principal Investigator), Osman Farooq (Co-Investigator), Michelle Hartley-McAndrew (Co-Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. 4/1/2011-8/1/2022.

Beverly Schaefer, MD

  • Impact of Obesity on Laboratory Profiles, Treatment and Outcomes of Individuals with Type 1 Von Willebrand Disease and Low Von Willebrand Factor. Beverly Schaefer (Principal Investigator). American Thrombosis and Hemostasis Network. $50,000. 7/1/2018-6/1/2019.
  • Robert Long Career Development Award. Beverly Schaefer (Principal Investigator). Hemophilia Center of Western New York. $890,000. 1/1/2018-1/1/2022.

Xiaozhong Wen, PhD

  • Snacking for Two (Impact of Changes in the Reinforcing Value of Food During Pregnancy in Smokers, Quitters, and Non-Smokers). Xiaozhong Wen (Co-Investigator). University at Buffalo. $10,000. 3/1/2019-6/1/2020.
  • Postpartum Smoking Relapse Prevention by Breastfeeding Promotion. Xiaozhong Wen (Principal Investigator). National Institutes of Health. $242,324. 8/1/2018-7/1/2020.
  • Maternal and Child Health Field-Initiated Research Program. Xiaozhong Wen (Principal Investigator). Health Resources and Services Administration. $99,995. 7/1/2018-6/1/2019.
  • Socioeconomic disparities in early origins of childhood obesity and body mass index trajectories. Xiaozhong Wen (Principal Investigator). HRSA - Health Resources and Services Administration. $99,995. 7/1/2018-6/1/2019.
  • CTSA Pilot: Pilot Study on Pediatric Obesity Prevention by Maternal Smoking Cessation in Pregnancy and Lactation. Xiaozhong Wen (Principal Investigator), Kai Ling Kong (Co-Investigator). National Institutes of Health. $75,000. 11/1/2015-3/1/2017.